The financial world is often divided into two categories: companies that make products and companies that make “announcements.” Evexia Lifecare Ltd, formerly known as Kavit Industries, seems to be mastering the latter with a flair that would make a Hollywood publicist blush. While the stock price languishes at a literal penny-stock level of ₹1.10, the balance sheet is screaming in a language that only auditors and brave souls can decipher.
With a Market Cap of ₹206 Cr and a staggering Debt of ₹1,222 Cr, the leverage here isn’t just high; it is atmospheric. The company is currently trading at a P/E of 127.48, which is a bold valuation for a business where 95% of the revenue comes from trading and the statutory auditor has just issued a “Qualified Opinion.” When an auditor uses words like “material misstatements” and “lack of appropriate audit evidence,” it’s time to stop looking at the ticker and start looking at the fine print.
1. At a Glance
If you enjoy financial thrillers where the protagonist is a balance sheet under siege, Evexia Lifecare is your top pick. We are looking at a company that claims to be in everything from Edible Oil and Plastic Granules to Precious Stones, Electric Vehicles, and Software Development. In the world of business, this is usually called “di-worsification.”
The numbers tell a story of extreme stress. The company reported a PAT of ₹0.78 Cr for the March 2026 quarter, while sitting on a debt pile that is nearly six times its market capitalization. Investors are paying 127 times earnings for a business that the auditor explicitly states has failed to assess “Expected Credit Loss” for loans and receivables worth nearly ₹36 Cr.
Red flags are not just waving here; they are being shot out of a cannon. The promoter holding has dwindled to a measly 3.36%. For context, when the owners of the house own less than 4% of the equity, you have to ask who is actually living there. Institutional interest is effectively zero, with FIIs holding a negligible 0.12%.
Despite these glaring structural issues, the stock has managed to attract over 1.44 lakh shareholders. This massive public floating of 96.41% suggests that the “smart money” left the building long ago, leaving the retail public to hold a very heavy, very indebted bag. The recent fine of ₹4,73,000 by BSE for board composition non-compliance is just the cherry on top of a very complicated corporate governance sundae.
Is this a diversified conglomerate in the making or a trading shell struggling under the weight of its own past? The auditor’s refusal to give a “Clean Opinion” suggests the latter. With FCCBs (Foreign Currency Convertible Bonds) worth millions of dollars being pushed out to a 2028 maturity, the clock is ticking, but the alarm has already been silenced by “management’s assessment.”
2. Introduction
Evexia Lifecare is a textbook case of a small-cap entity trying to reinvent itself every few seasons. Originally incorporated in 1990, it has transitioned through names and business models like a chameleon on a disco floor.
The company operates out of Vadodara, Gujarat, and has managed to stay in the news not for its breakthrough products, but for its complex financial engineering. From stock splits to issuance of convertible warrants and the constant restructuring of its Foreign Currency Convertible Bonds (FCCBs), the corporate action diary is busier than the sales ledger.
Currently, the company’s main bread and butter—accounting for 95% of revenue—is trading. It buys and sells chemicals, agricultural produce, and consumer goods. While the “Manufactured Products” segment sounds more prestigious, it contributes a tiny 2% to the top line.
The recent push into Electric Vehicles (EVs) and Petrochemicals adds a layer of “future-ready” buzzwords to the profile, but the underlying financials show a company that is heavily reliant on “Other Income” and paper adjustments to stay in the green. With the auditors raising concerns about the recoverability of trade receivables and loans, the “Introduction” to Evexia is less of a handshake and more of a warning.
3. Business Model – WTF Do They Even Do?
If you ask management what they do, the answer is “Yes.” Evexia Lifecare is a “Jack of all trades” that has seemingly forgotten
